[Churg-Strauss syndrome under omalizumab treatment: a rare visceral manifestation].
Szwarc
D
D
Service de Radiologie, Hôpital de Hautepierre, Strasbourg Cedex, France. daniel.szwarc@chru-strasbourg.fr
Veillon
F
F
Moser
T
T
Averous
G
G
De Blay
F
F
Riehm
S
S
D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D015267:Churg-Strauss Syndrome / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab
D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab